ZA879459B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA879459B
ZA879459B ZA879459A ZA879459A ZA879459B ZA 879459 B ZA879459 B ZA 879459B ZA 879459 A ZA879459 A ZA 879459A ZA 879459 A ZA879459 A ZA 879459A ZA 879459 B ZA879459 B ZA 879459B
Authority
ZA
South Africa
Prior art keywords
medicaments
antagonist
receptors
compound
conjunction
Prior art date
Application number
ZA879459A
Other languages
English (en)
Inventor
Michael Brian Tyers
Brian Tyers Michael
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA879459B publication Critical patent/ZA879459B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA879459A 1986-12-17 1987-12-17 Medicaments ZA879459B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630080A GB8630080D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
ZA879459B true ZA879459B (en) 1988-11-30

Family

ID=10609121

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879459A ZA879459B (en) 1986-12-17 1987-12-17 Medicaments

Country Status (10)

Country Link
EP (1) EP0272876B1 (da)
JP (1) JPS63246337A (da)
AT (1) ATE95704T1 (da)
AU (1) AU618943B2 (da)
CA (1) CA1314223C (da)
DE (1) DE3787796T2 (da)
DK (1) DK662487A (da)
ES (1) ES2059399T3 (da)
GB (1) GB8630080D0 (da)
ZA (1) ZA879459B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
WO1993012817A1 (en) * 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
WO1997047285A1 (en) * 1996-06-10 1997-12-18 Depomed, Inc. Gastric-retentive oral controlled drug delivery system with enhanced retention properties
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
MXPA05011699A (es) * 2003-05-06 2006-01-23 Altana Pharma Ag Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
DE3771376D1 (de) * 1986-03-17 1991-08-22 Glaxo Group Ltd Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
DK662487D0 (da) 1987-12-16
EP0272876A2 (en) 1988-06-29
DK662487A (da) 1988-06-18
DE3787796T2 (de) 1994-03-03
ATE95704T1 (de) 1993-10-15
JPS63246337A (ja) 1988-10-13
CA1314223C (en) 1993-03-09
GB8630080D0 (en) 1987-01-28
ES2059399T3 (es) 1994-11-16
EP0272876B1 (en) 1993-10-13
EP0272876A3 (en) 1988-07-27
AU618943B2 (en) 1992-01-16
DE3787796D1 (de) 1993-11-18
AU8261587A (en) 1988-06-23

Similar Documents

Publication Publication Date Title
FR2624720B1 (fr) Implant pour dispositif d'osteosynthese, notamment du rachis
FR2617041B1 (fr) Orthese ou prothese pour la coordination des mouvements
EP0188081A3 (en) Use of paroxetine for the treatment of obesity
GB8518658D0 (en) Medicaments
GB8630080D0 (en) Medicaments
ES8801190A1 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas.
GR3017369T3 (en) Use of heterocyclic derivatives in the treatment of cognitive disorders.
IT8349596A0 (it) Preparato medicinale per la cura dell'ulcera gastroduodenale
FR2556956B3 (fr) Prothese penienne semi-rigide pour le traitement des impuissances d'erection
IT9041529A0 (it) Dispositivo per la correzione chirurgica dell'ametropia
GB8630079D0 (en) Medicaments
IT1199114B (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
BE872108A (fr) Dispositif pour l'epuration biologique des eaux usees
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
ZA822193B (en) 5,6-dihydro-11-alkylene-morphanthridin-6-ones,their preparation,and drugs containing these compounds
IT8047950A0 (it) Composizioni farmaceutiche impiegabili per il trattamento dell'ipertensione
ATE31925T1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide.
FR2542607B1 (fr) Module autostatique d'abduction des membres inferieurs
ZA903015B (en) Therapeutic use of 5-ht3 receptor antagonists
FR2686246B3 (fr) Orthese de poignet pour le traitement de l'epicondylalgie.
IT9067177A0 (it) Mezzi per il trattamento terapeutico dell'apnea durante il sonno
ZA914755B (en) Treatment of gastric disorders using histamine h2-receptor antagonist compositions
RO89346A2 (ro) Dispozitiv pentru intinderea curelelor trapezoidale
IT7922956V0 (it) Coordinato portatile per l'igiene del cavo orale.